Yumanity Therapeutics Inc. (YMTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Yumanity Therapeutics Inc...

    NASDAQ: YMTX · Real-Time Price · USD
    1.89
    0.15 (8.62%)
    At close: Dec 19, 2022, 6:00 AM

    Yumanity Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 5.44M 1.95M 9.09M
    Cost of Revenue
    		 n/a 9K 734K 669K
    Gross Profit
    		 n/a 5.43M 1.22M 8.42M
    Operating Income
    		 -13.53M -15.72M -41.53M -11.09M
    Interest Income
    		 111K 325K 9K n/a
    Pretax Income
    		 -17.13M -14.08M -63.45M -11.82M
    Net Income
    		 -17.13M -14.1M -63.07M -11.96M
    Selling & General & Admin
    		 8.14M 12.14M 8.7M 4.62M
    Research & Development
    		 5.39M 9.02M 34.79M 15.56M
    Other Expenses
    		 n/a n/a -18.53M -1.15M
    Operating Expenses
    		 13.53M 21.16M 43.48M 20.18M
    Interest Expense
    		 138K 337K 3.74M 1.29M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 n/a 21.16M 43.48M 20.18M
    Income Tax Expense
    		 n/a n/a -386K 143K
    Shares Outstanding (Basic)
    		 12.1M 11.05M 4.93M 1.47M
    Shares Outstanding (Diluted)
    		 12.1M 11.05M 4.93M 1.47M
    EPS (Basic)
    		 -1.42 -1.28 -12.8 -8.14
    EPS (Diluted)
    		 -1.42 -1.28 -12.8 -8.14
    EBITDA
    		 -13.53M -15.71M -41.53M -10.42M
    EBIT
    		 n/a -13.74M -59.72M -10.52M
    Depreciation & Amortization
    		 n/a 9K 734K 669K

    Add to Watchlist